Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of the PPAR genes and cardiovascular disease.

Pharmacogenomics - 1 Nov 2007

Cresci Sharon

Abstract excerpt

The goal of pharmacogenetics is to define the genetic determinants of individual drug responsiveness, and thereby provide personalized treatment to each individual. The peroxisome proliferator-activated receptors (PPARs) are polypeptide products of a set of related genes functioning to regulate several cellular processes that are central to cardiovascular health and disease. Given their pleiotropic roles in lipid...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Genetic Variation
Share to Ligands

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Peroxisome Proliferator-Activated Receptors

Share to Pharmacogenetics

Share to Treatment Outcome

Source

Identifiers

PMID: 18034623
DOI: 10.2217/14622416.8.11.1581

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of the PPAR genes and cardiovascular disease.PMID 18034623Read ↗

PPARs and their Effects on the Cardiovascular SystemSemantic proximity Read ↗

Peroxisome proliferator-activated receptors and the cardiovascular system.Semantic proximity Read ↗

PPARγ Gene Polymorphisms, Metabolic Disorders, and Coronary Artery DiseaseSemantic proximity Read ↗

PPARs: Regulators of Metabolism and As Therapeutic Targets in Cardiovascular disease. Part I: PPAR-αSemantic proximity Read ↗

Cardiovascular pharmacogenetics of antihypertensive and lipid- lowering therapies.Semantic proximity Read ↗

Understanding diet-gene interactions: lessons from studying nutrigenomics and cardiovascular disease.Semantic proximity Read ↗

Role of the Peroxisome Proliferator Activated Receptors in HypertensionSemantic proximity Read ↗

PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid.Semantic proximity Read ↗

Pleiotropic actions of PPAR gamma activators thiazolidinediones in cardiovascular diseases.Semantic proximity Read ↗

Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis.Semantic proximity Read ↗

Peroxisome proliferator-activated receptors as molecular targets in relation to obesity and type 2 diabetes.Semantic proximity Read ↗

Pharmacogenomics of cardiovascular complications in diabetes and obesity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.